CASTLE BIOSCIENCES INC
Profile
Company Names
CASTLE BIOSCIENCES INC
Addresses
820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX 77546
2014 SAN MIGUEL DR, FRIENDSWOOD, TX 77546
Phone Numbers
866-788-9007
281-796-9032
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2007
State Incorporated:
DE
Total Amount Raised:
$59,935,744.00
Number of Funding Rounds:
13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2019-07-12
$10,000,000.00
$20,000,000.00
$10,000,000.00
Debt
12
2019-01-31
$11,770,375.00
$11,770,500.00
$125.00
Debt
11
2018-05-31
$5,058,036.00
$5,250,000.00
$191,964.00
Equity
10
2018-01-12
$5,475,746.00
$5,475,746.00
$0.00
Equity
9
2015-07-15
$11,700,000.00
$20,000,000.00
$8,300,000.00
Equity
8
2014-08-11
$7,518,000.00
$11,982,000.00
$4,464,000.00
Equity
7
2014-04-22
$1,000,000.00
$1,000,000.00
$0.00
Equity, Debt
6
2013-11-08
$1,000,000.00
$2,000,000.00
$1,000,000.00
Equity, Debt
5
2013-05-02
$1,508,000.00
$1,508,000.00
$0.00
Equity
4
2012-09-21
$1,343,689.00
$1,343,689.00
$0.00
Equity
3
2011-09-02
$1,501,000.00
$1,501,000.00
$0.00
Equity
2
2010-03-02
$1,124,999.00
$1,755,001.00
$630,002.00
Equity, Debt
1
2008-09-12
$935,899.00
$1,280,717.00
$344,818.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL
BRADBURY
DIRECTOR
DANIEL
M.
BRADBURY
DIRECTOR
JOSEPH
C.
COOK, III
DIRECTOR
JOSEPH
C.
COOK, JR.
DIRECTOR
DAVID
KABAKOFF, PH.D.
DIRECTOR
GARHENG
KONG
DIRECTOR
CEMPRA HOLDINGS, LLC
| APPLIED GENETIC TECHNOLOGIES CORP
| VIAMET PHARMACEUTICALS INC
| ALDAGEN INC
| TRANSENTERIX INC
| CANCERGUIDE DIAGNOSTICS, INC.
| SARCODE BIOSCIENCE INC.
| SOFINNOVA VENTURE PARTNERS VIII, L.P.
| HISTOGENICS CORP
| CEMPRA, INC.
| ALIMERA SCIENCES INC
| FIRST AID BEVERAGES, INC.
| SOFINNOVA HEALTHQUEST PARTNERS, L.P.
| TRICE MEDICAL, INC.
| LONGWOOD OPPORTUNITY OFFSHORE FUND, LTD
| LONGWOOD OFFSHORE, LTD.
| CASTLE BIOSCIENCES INC
| STRONGBRIDGE BIOPHARMA PLC
| ACUTA OPPORTUNITY OFFSHORE FUND, LTD.
| ACUTA CAPITAL OFFSHORE FUND, LTD.
| HEALTHQUEST PARTNERS II, L.P.
| MAGNOLIA MEDICAL TECHNOLOGIES, INC.
| VENUS CONCEPT LTD.
| ALCRESTA THERAPEUTICS, INC.
| MELINTA THERAPEUTICS, INC. /NEW/
| AVEDRO INC
| CLEANSLATE CENTERS, INC.
| BARDY DIAGNOSTICS, INC.
| HEALTHQUEST PARTNERS III, L.P.
| HEALTHQUEST AJAX II SPV, L.P.
| AJAX HEALTH II LLC
| VENUS CONCEPT INC.
| HEALTHQUEST AJAX III SPV, L.P.
| AJAX HEALTH III LLC
| HEALTHQUEST AJAX III-A SPV, L.P.
| HEALTHQUEST MADISON SPV, L.P.
| HEALTHQUEST PARTNERS IV, L.P.
| HEALTHQUEST TACTICAL OPPORTUNITIES FUND, L.P.
| HOME HOSPITAL NEWCO, INC.
| HQTOF ENDEAVOR SPV, L.P.
| HQTOF ENDEAVOR SPV-B, L.P.
| NOMAD HEALTH, INC.
DEREK
MAETZOLD
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
Debt
2019-07-12
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE
N/A
NONE
N/A
NONE

